Skip to main content
Top
Published in: Journal of Endocrinological Investigation 6/2014

01-06-2014 | Original Article

Comparison between liquid and tablet levothyroxine formulations in patients treated through enteral feeding tube

Authors: I. Pirola, L. Daffini, E. Gandossi, D. Lombardi, A. Formenti, M. Castellano, C. Cappelli

Published in: Journal of Endocrinological Investigation | Issue 6/2014

Login to get access

Abstract

Background

The majority of clinicians suggest that enteral feedings should be held 1–2 h prior to and after L-T4 administration despite lack of data for continuous enteral nutrition.

Aim

The aim of this study was to: (1) compare the thyroid hormonal profile in patients submitted to L-T4 treatment in tablets or liquid formulation with an enteral feeding tube; (2) evaluate the nursing compliance with the two different formulations.

Subjects and methods

20 euthyroid patients submitted to total laryngectomy and thyroidectomy consecutively started L-T4 treatment in tablets (Group T) or in liquid formulation (Group L) with enteral feeding tube the day after surgery. Tablets were crushed before administration and enteral feeding was stopped for 30 min before and after L-T4 treatment, whereas liquid formulation was placed into the nasoenteric tube immediately. A questionnaire about the preparation and administration of thyroxine replacement therapy was given to the nurses.

Results

No difference of TSH, fT4 and fT3 before and after L-T4 treatment was observed among patients of Group L. A slightly serum TSH increase was observed in Group T, but not reaching statistical significance (2.50 ± 1.18 vs 2.94 ± 1.22 mUI/L), whereas no difference in fT4 and fT3 levels was found. Preparation and administration of liquid L-T4 was considered excellent by 12/13 nurses, whereas tablet formulation was considered poor by 10/13.

Conclusions

Our data showed that liquid L-T4 formulation can be administered directly through feeding tube with no need for an empty stomach, with a significant improvement in therapy preparation and administration by nurses.
Literature
1.
go back to reference Mendelson AA, Al-Khatib TA, Julien M et al (2009) Thyroid gland management in total laryngectomy: meta-analysis and surgical recommendations. Otolaryngol Head Neck Surg 140:298–305PubMedCrossRef Mendelson AA, Al-Khatib TA, Julien M et al (2009) Thyroid gland management in total laryngectomy: meta-analysis and surgical recommendations. Otolaryngol Head Neck Surg 140:298–305PubMedCrossRef
2.
go back to reference Ho AC, Ho WK, Lam PK et al (2008) Thyroid dysfunction in laryngectomees—10 years after treatment. Head Neck 30:336–340PubMedCrossRef Ho AC, Ho WK, Lam PK et al (2008) Thyroid dysfunction in laryngectomees—10 years after treatment. Head Neck 30:336–340PubMedCrossRef
3.
go back to reference Martín Villares C, Fernández Pello ME, San Román Carbajo J et al (2003) Postoperative nutrition in patients with head and neck cancer. Nutr Hosp 18:243–247PubMed Martín Villares C, Fernández Pello ME, San Román Carbajo J et al (2003) Postoperative nutrition in patients with head and neck cancer. Nutr Hosp 18:243–247PubMed
4.
go back to reference Pacini F, Castagna MG (2012) Approach to and treatment of differentiated thyroid carcinoma. Med Clin N Am 96:369–383PubMedCrossRef Pacini F, Castagna MG (2012) Approach to and treatment of differentiated thyroid carcinoma. Med Clin N Am 96:369–383PubMedCrossRef
5.
go back to reference Almandoz JP, Gharib H (2012) Hypothyroidism: etiology, diagnosis, and management. Med Clin N Am 96:203–221PubMedCrossRef Almandoz JP, Gharib H (2012) Hypothyroidism: etiology, diagnosis, and management. Med Clin N Am 96:203–221PubMedCrossRef
6.
go back to reference Wenzel KW, Kirschsieper HE (1977) Aspects of the absorption of oral L-thyroxine in normal man. Metabolism 26:1–8PubMedCrossRef Wenzel KW, Kirschsieper HE (1977) Aspects of the absorption of oral L-thyroxine in normal man. Metabolism 26:1–8PubMedCrossRef
7.
go back to reference Centanni M, Gargano L, Canettieri G et al (2006) Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med 354:1787–1795PubMedCrossRef Centanni M, Gargano L, Canettieri G et al (2006) Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med 354:1787–1795PubMedCrossRef
8.
go back to reference Checchi S, Montanaro A, Pasqui L et al (2008) l-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies. J Clin Endocrinol Metab 93:465–469PubMedCrossRef Checchi S, Montanaro A, Pasqui L et al (2008) l-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies. J Clin Endocrinol Metab 93:465–469PubMedCrossRef
10.
go back to reference Sherman SI, Malecha SE (1995) Absorption and malabsorption of levothyroxine sodium. Am J Ther 2:814–818PubMedCrossRef Sherman SI, Malecha SE (1995) Absorption and malabsorption of levothyroxine sodium. Am J Ther 2:814–818PubMedCrossRef
11.
go back to reference Mechanick JI, Brett EM (2002) Nutrition Support of the chronically critically ill patient. Crit Care Clin 18:597–618PubMedCrossRef Mechanick JI, Brett EM (2002) Nutrition Support of the chronically critically ill patient. Crit Care Clin 18:597–618PubMedCrossRef
12.
go back to reference Yue CS, Scarsi C, Ducharme MP (2012) Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms. Arzneimittelforschung 62:631–636PubMedCrossRef Yue CS, Scarsi C, Ducharme MP (2012) Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms. Arzneimittelforschung 62:631–636PubMedCrossRef
13.
go back to reference Cappelli C, Pirola I, Gandossi E, Formenti A, Castellano M (2013) Oral liquid levothyroxine treatment at breakfast: a mistake? Eur J Endocrinol 170:95–99PubMedCrossRef Cappelli C, Pirola I, Gandossi E, Formenti A, Castellano M (2013) Oral liquid levothyroxine treatment at breakfast: a mistake? Eur J Endocrinol 170:95–99PubMedCrossRef
14.
go back to reference Santini F, Pinchera A, Marsili A et al (2005) Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J Clin Endocrinol Metab 90:124PubMedCrossRef Santini F, Pinchera A, Marsili A et al (2005) Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J Clin Endocrinol Metab 90:124PubMedCrossRef
15.
go back to reference Naber TH, Schermer T, de Bree A et al (1997) Prevalence of malnutrition in nonsurgical hospitalized patients and its association with disease complications. Am J Clin Nutr 66:1232PubMed Naber TH, Schermer T, de Bree A et al (1997) Prevalence of malnutrition in nonsurgical hospitalized patients and its association with disease complications. Am J Clin Nutr 66:1232PubMed
16.
go back to reference Martyn CN, Winter PD, Coles SJ et al (1998) Effect of nutritional status on use of health care resources by patients with chronic disease living in the community. Clin Nutr 17:119PubMedCrossRef Martyn CN, Winter PD, Coles SJ et al (1998) Effect of nutritional status on use of health care resources by patients with chronic disease living in the community. Clin Nutr 17:119PubMedCrossRef
17.
go back to reference Chima CS, Barco K, Dewitt ML et al (1997) Relationship of nutritional status to length of stay, hospital costs, and discharge status of patients hospitalized in the medicine service. J Am Diet Assoc 97:975PubMedCrossRef Chima CS, Barco K, Dewitt ML et al (1997) Relationship of nutritional status to length of stay, hospital costs, and discharge status of patients hospitalized in the medicine service. J Am Diet Assoc 97:975PubMedCrossRef
18.
go back to reference Rollins CJ (1995) Adult enteral nutrition. In: Koda-Kimble MA et al, eds. Applied therapeutics: the clinical use of drugs. 6th ed, Chap 34. Applied Therapeutics, Vancouver, pp 1–28 Rollins CJ (1995) Adult enteral nutrition. In: Koda-Kimble MA et al, eds. Applied therapeutics: the clinical use of drugs. 6th ed, Chap 34. Applied Therapeutics, Vancouver, pp 1–28
19.
go back to reference Beckwith MC, Feddema SS, Barton RG et al (2004) A Guide to drug therapy in patients with enteral feeding tubes: dosage form selection and administration methods. J Hosp Pharm 39:225–237 Beckwith MC, Feddema SS, Barton RG et al (2004) A Guide to drug therapy in patients with enteral feeding tubes: dosage form selection and administration methods. J Hosp Pharm 39:225–237
20.
go back to reference Lamson MJ, Pamplin CL, Rolleri RL et al (2004) Quantitation of a substantial reduction in levothyroxine (T4) absorption by food. Thyroid 14:876 Lamson MJ, Pamplin CL, Rolleri RL et al (2004) Quantitation of a substantial reduction in levothyroxine (T4) absorption by food. Thyroid 14:876
21.
go back to reference Dickerson RN, Maish GO, Minard G et al (2010) Clinical relevancy of the levothyroxine-continuous enteral nutrition interaction. Nutr Clin Pract 25:646–652PubMedCrossRef Dickerson RN, Maish GO, Minard G et al (2010) Clinical relevancy of the levothyroxine-continuous enteral nutrition interaction. Nutr Clin Pract 25:646–652PubMedCrossRef
22.
go back to reference Phillips NM, Nay R (2007) Nursing administration of medication via enteral tubes in adults: a systematic review. Int J Evid Based Healthc 5:324–353PubMed Phillips NM, Nay R (2007) Nursing administration of medication via enteral tubes in adults: a systematic review. Int J Evid Based Healthc 5:324–353PubMed
23.
go back to reference Seifert CF, Frye JL, Belknap DC et al (1995) A nursing survey to determine the characteristics of medication administration through enteral feeding catheters. Clin Nurs Res 4:290–305PubMedCrossRef Seifert CF, Frye JL, Belknap DC et al (1995) A nursing survey to determine the characteristics of medication administration through enteral feeding catheters. Clin Nurs Res 4:290–305PubMedCrossRef
24.
go back to reference Mota ML, Barbosa IV, Studart RM et al (2010) Evaluation of intensivist-nurses’ knowledge concerning medication administration through nasogastric and enteral tubes. Rev Lat Am Enfermagem 18:888–894PubMed Mota ML, Barbosa IV, Studart RM et al (2010) Evaluation of intensivist-nurses’ knowledge concerning medication administration through nasogastric and enteral tubes. Rev Lat Am Enfermagem 18:888–894PubMed
25.
go back to reference Mitchell JF, Pawlicki KS (1996) Oral solid dosage forms that should not be crushed: 1994 revision. Hosp Pharm 29(666–8):670–675 Mitchell JF, Pawlicki KS (1996) Oral solid dosage forms that should not be crushed: 1994 revision. Hosp Pharm 29(666–8):670–675
26.
go back to reference Manessis A, Lascher S, Bukberg P et al (2008) Quantifying amount of adsorption of levothyroxine by percutaneous endoscopic gastrostomy tubes. JPEN J Parenter Enteral Nutr 32:197–200PubMedCrossRef Manessis A, Lascher S, Bukberg P et al (2008) Quantifying amount of adsorption of levothyroxine by percutaneous endoscopic gastrostomy tubes. JPEN J Parenter Enteral Nutr 32:197–200PubMedCrossRef
27.
go back to reference Vita R, Saraceno G, Trimarchi F, Benvenga S (2013) A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations. Endocrine 43:154–160PubMedCrossRef Vita R, Saraceno G, Trimarchi F, Benvenga S (2013) A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations. Endocrine 43:154–160PubMedCrossRef
28.
go back to reference Peroni E, Vigone MC, Mora S et al (2013) Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine. Horm Res Paediatr (in press) Peroni E, Vigone MC, Mora S et al (2013) Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine. Horm Res Paediatr (in press)
29.
go back to reference Bernareggi A, Grata E, Pinorini MT, Conti A (2013) Oral liquid formulation of levothyroxine is stable in breakfast beverages and may improve thyroid patient compliance. Pharmaceutics 5:621–633PubMedCentralPubMedCrossRef Bernareggi A, Grata E, Pinorini MT, Conti A (2013) Oral liquid formulation of levothyroxine is stable in breakfast beverages and may improve thyroid patient compliance. Pharmaceutics 5:621–633PubMedCentralPubMedCrossRef
30.
go back to reference Garber JR, Cobin RH, Gharib H et al (2012) Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 18:988–1028PubMedCrossRef Garber JR, Cobin RH, Gharib H et al (2012) Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 18:988–1028PubMedCrossRef
31.
go back to reference Golger A, Fridman TR, Eski S et al (2003) Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma. J Endocrinol Invest 26:1023–1031PubMedCrossRef Golger A, Fridman TR, Eski S et al (2003) Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma. J Endocrinol Invest 26:1023–1031PubMedCrossRef
Metadata
Title
Comparison between liquid and tablet levothyroxine formulations in patients treated through enteral feeding tube
Authors
I. Pirola
L. Daffini
E. Gandossi
D. Lombardi
A. Formenti
M. Castellano
C. Cappelli
Publication date
01-06-2014
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 6/2014
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-014-0082-9

Other articles of this Issue 6/2014

Journal of Endocrinological Investigation 6/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.